GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » ROC (Joel Greenblatt) %

Cognetivity Neurosciences (Cognetivity Neurosciences) ROC (Joel Greenblatt) % : -5,654.79% (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Cognetivity Neurosciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -5,654.79%.

The historical rank and industry rank for Cognetivity Neurosciences's ROC (Joel Greenblatt) % or its related term are showing as below:

CGNSF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -24424.3   Med: -15900   Max: -4600
Current: -7209.51

During the past 7 years, Cognetivity Neurosciences's highest ROC (Joel Greenblatt) % was -4600.00%. The lowest was -24424.30%. And the median was -15900.00%.

CGNSF's ROC (Joel Greenblatt) % is ranked worse than
97.41% of 657 companies
in the Healthcare Providers & Services industry
Industry Median: 9.69 vs CGNSF: -7209.51

Cognetivity Neurosciences's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 12.10% per year.


Cognetivity Neurosciences ROC (Joel Greenblatt) % Historical Data

The historical data trend for Cognetivity Neurosciences's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences ROC (Joel Greenblatt) % Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial -22,628.57 -8,287.50 -4,647.62 -24,360.00 -9,943.75

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,714.89 -10,597.85 -6,507.87 -5,609.76 -5,654.79

Competitive Comparison of Cognetivity Neurosciences's ROC (Joel Greenblatt) %

For the Health Information Services subindustry, Cognetivity Neurosciences's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's ROC (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's ROC (Joel Greenblatt) % falls into.



Cognetivity Neurosciences ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jul. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.203 + 0 + 0.037) - (3.817 + 0.096 + 5.561)
=-9.234

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.184 + 0 + 0.025) - (4.137 + 0.079 + 6.223)
=-10.23

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Cognetivity Neurosciences for the quarter that ended in Oct. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Oct. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2023  Q: Oct. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.064/( ( (0.039 + max(-9.234, 0)) + (0.034 + max(-10.23, 0)) )/ 2 )
=-2.064/( ( 0.039 + 0.034 )/ 2 )
=-2.064/0.0365
=-5,654.79 %

Note: The EBIT data used here is four times the quarterly (Oct. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Cognetivity Neurosciences ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019